Atazanavir Sulfate

NDC 65862-713 · Aurobindo Pharma Limited

Generic nameAtazanavir

Dosage formCAPSULE

RouteORAL

Active ingredient(s)ATAZANAVIR SULFATE

Strength300 mg/1

Pharmacologic classCytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inhibitors [MoA], UGT1A1 Inhibitors [MoA]

Marketing categoryANDA

Packages

65862-713-03 — 3 BLISTER PACK in 1 CARTON (65862-713-03) / 10 CAPSULE in 1 BLISTER PACK (65862-713-10)

65862-713-05 — 500 CAPSULE in 1 BOTTLE (65862-713-05)

65862-713-30 — 30 CAPSULE in 1 BOTTLE (65862-713-30)

65862-713-90 — 90 CAPSULE in 1 BOTTLE (65862-713-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0003-3622 — ATAZANAVIR, 0003-3631 — ATAZANAVIR, 0003-3638 — ATAZANAVIR, 0003-3641 — atazanavir and cobicistat, 0093-5526 — Atazanavir Sulfate, 0093-5527 — Atazanavir Sulfate, 0093-5528 — Atazanavir Sulfate, 31722-653 — Atazanavir, 31722-654 — Atazanavir, 31722-655 — Atazanavir, 42385-920 — Atazanavir, 42385-921 — Atazanavir, 42385-922 — Atazanavir, 65862-710 — Atazanavir, 65862-711 — Atazanavir, 65862-712 — Atazanavir

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.